Furthermore, the intracellular transcription factor Nurr1 has been suggested as a therapeutic target since it undergoes alterations and is involved in the pathology of neurodegenerative diseases including Parkinson’s disease (PD) and Alzheimer’s disease (AD) [17,18,19,20,21,22,23]. This evidence concerns the gene NR4A2 and Parkinson disease.